Welcoming Two New Board Members: Dr. Mika Matsuzaki and Dr. Susan M. Jerian
Please join us in welcoming Mika Matsuzaki, PhD, and Susan M. Jerian, MD to The Max Foundation Board of Directors.
Join us November 6th for the International CML Foundation Forum at AORTIC
The African Organization for Research and Training in Cancer conference (AORTIC), happening November 5–8, 2019 brings together leading cancer specialists from around the world.
During the conference, attendees are invited to join The Max Foundation and the International and Chronic Myeloid Leukemia Foundation (iCMLf) for an interactive session for African Physicians Treating CML.
When:
Wednesday, November 6 from 5–8 PM at the Radisson Blu Hotel, adjacent to the AORTIC conference center in Maputo, Mozambique.
Discussion Topics:
In this session leading physicians and experts will discuss the following:
- Monitoring CML in a low-resource setting
- Responsible management in the era of 5 TIKs
- Meet the expert: Small group discussions
Get to know the speakers:
- Oliver Henke (Tanzania/Germany) |Professional Bio
- Amma Benneh Akwasi Kuma (Ghana) | Professional Bio
- Professor Tim Hughes (Australia) | Professional Bio
- Anthony Oyekunle (Nigeria/Botswana) | Professional Bio
- Durosinmi (Nigeria) | Professional Bio
- Gebremedhin (Ethiopie) | Professional Bio
This is an opportunity to join in-person to learn from the experts and exchange valuable ideas and transformative practices. Light dinner refreshments will be served.
To reserve your place please email Arlene Harris-Buchan.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Max Foundation Expands Agreement with Bristol-Myers Squibb
The Max Foundation is proud to announce it has signed an expanded collaboration agreement with Bristol-Myers Squibb – a committed pharmaceutical partner and member of our humanitarian pact.
The Max Foundation Renews and Expands Agreement with Incyte
The Max Foundation has renewed and expanded its treatment-access agreement with Incyte in Europe. The agreement will now provide treatment access for up to 50 patients in Eastern Europe and Central Asia.